1.0Target Pharmahttps://targetpharma.gr/en/managerhttps://targetpharma.gr/en/author/manager/rich600338<blockquote class="wp-embedded-content" data-secret="K8ZGcN4EoJ"><a href="https://targetpharma.gr/en/product/minoxidil-target/">Minoxidil / Target®cutaneous solution</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://targetpharma.gr/en/product/minoxidil-target/embed/#?secret=K8ZGcN4EoJ" width="600" height="338" title="“Minoxidil / Target®cutaneous solution” — Target Pharma" data-secret="K8ZGcN4EoJ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://targetpharma.gr/wp-includes/js/wp-embed.min.js </script> https://targetpharma.gr/wp-content/uploads/2017/10/minoxidil-combo.jpg480600Brand name MINOXIDIL/TARGET® cutaneous solution Active Substance Minoxidil Pharaceutical Form cut. Sol. Strength 5% w/v Package FL x 60 ml Administration Route Topical cutaneous use ATC D11AX01 System Dermatologicals Therapeutic category Other dermatological preparations Specialties GPs, Internist, Dermatologist Action For the treatment of alopecia androgenetica. Please read more information in the Information leaflet.